Outline

JEIM

Ascorbic Acid–Driven Redox Modulation of Dihydroartemisinin Antimalarial Mechanisms

Author(s): Ifeoma Nwankwo1, Adaora Adimora1
1School of Medicine and UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Nwankwo, Ifeoma . and Adimora, Adaora . “Ascorbic Acid–Driven Redox Modulation of Dihydroartemisinin Antimalarial Mechanisms.” Journal of Computational and Engineering Sciences Press: 16-20, doi:.

Abstract

Artemisinin derivatives exert rapid antimalarial activity primarily through iron-dependent
radical generation and oxidative damage within Plasmodium parasites. Concurrent administration
of antioxidant supplements during malaria therapy is common in endemic regions,
yet their mechanistic impact on artemisinin efficacy remains poorly understood. This study
investigates the redox- and iron-mediated mechanisms underlying the interaction between
dihydroartemisinin (DHA) and ascorbic acid (AA) in a Plasmodium berghei-infected murine
model. Biochemical analyses of oxidative stress markers, antioxidant enzyme systems,
labile iron pools, and heme metabolism were conducted alongside parasitemia and hepatic
injury assessment. The findings demonstrate that AA significantly attenuates DHA-induced
oxidative stress and disrupts iron-dependent radical formation, leading to reduced parasite
clearance and altered hepatic redox balance. These results provide mechanistic evidence that
antioxidant supplementation can compromise artemisinin efficacy and highlight the need for
evidence-based guidance regarding adjunctive vitamin use during antimalarial therapy.

Keywords
Dihydroartemisinin, Ascorbic Acid, Oxidative Stress, Iron Metabolism, Artemisinin Resistance, Malaria.

Related Articles

Azra Nishat1, Shazadi Sultana2, Arshiya Sultana2
1Department of Obstetrics and Gynecology, Government Nizamia Tibbi College Charminar, Hyderabad, India
2Department of Obstetrics and Gynecology, National Institute of Unani Medicine, PG Institute of Research, Bengaluru, Karnataka, India.
Rinaldo Bellomo1,2, John A. Kellum3, Claudio Ronco4
1Department of Intensive Care, Austin Hospital, Melbourne, Australia
2School of Medicine, The University of Melbourne, Australia
3Center for Critical Care Nephrology, University of Pittsburgh, USA.
4International Renal Research Institute, Vicenza, Italy.
Ivica Letunic1, Lars Nielsen1, Peer Bork2,3
1Biobyte solutions GmbH, Bothestr 142, 69126 Heidelberg, German
2EMBL, Meyerhofstrasse 1, 69117 Heidelberg, Germany.
3Department of Bioinformatics, Biocenter, University of Würzburg, Würzburg, Germany.
Michael Henderson1, Carol Inatsuka2, Amanda J. Sheets1, Corinne L. Williams3, David J. Benaron2, Gina M. Donato4, Mary C. Gray4, Erik L. Hewlett4, Peggy A. Cotter1,3
1Department of Microbiology and Immunology, School of Medicine, University of North Carolina at Chapel Hill, USA.
2Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, USA.
3Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, USA
4Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, USA
Eisha Nisar1, Rong Chen2, Atul Janardhan Butte2
1Faisalabad Medical University, faisalabad, Pakistan.
2Lucile Packard Children’s Hospital, Palo Alto, California, USA.
Robin Weiss1,2, Nicholas Wright1, Magdi Yacoub2, Roye Calne2
1Research Computing Center, University of Chicago, Chicago, IL 60637, USA.
2CCSN High Performance Electrical Neuroimaging Laboratory, University of Chicago, Chicago, IL 60637, USA .